FDA has approved the
first use of donated plasma from a recovered COVID-19 patient to treat a
critically ill patient who is hospitalized at Houston Methodist.
Recruitment in New York should start in the next few days for plasma
donations.
FDA has further amended its standards
for approving COVID-19 tests allowing laboratories to begin testing
prior to agency review of validation data. In the first week, six labs
took advantage.
Todos Medical Ltd. (OTCQB:TOMDF +22.5%) has expanded its
exclusive distribution deal with Shanghai Liangrun Biomedicine
Technology Co. subsidiary Gibraltar Brothers & Associates to include
polymerase chain reaction (PCR) testing kits in addition to a colloidal
gold IgM/IgG immunochromatography antibody test. Todos will
commercialize the tests through its COVID-19-focused joint venture with
Emerald Organic Products.
https://seekingalpha.com/news/3556363-covidminus-19-activities-healthcare
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.